BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 728149)

  • 1. A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
    Greenwald JE; Wong LK; Rao M; Bianchine JR; Panganamala RV
    Biochem Biophys Res Commun; 1978 Oct; 84(4):1112-8. PubMed ID: 728149
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats.
    Karpen CW; Pritchard KA; Merola AJ; Panganamala RV
    Prostaglandins Leukot Med; 1982 Feb; 8(2):93-103. PubMed ID: 6804992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inhibition of thromboxane biosynthesis by hydralazine.
    Greenwald JE; Wong LK; Alexander M; Bianchine JR
    Adv Prostaglandin Thromboxane Res; 1980; 6():293-5. PubMed ID: 7386270
    [No Abstract]   [Full Text] [Related]  

  • 4. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth I; Förster W
    Prostaglandins Leukot Med; 1984 Apr; 14(1):13-4. PubMed ID: 6427789
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of platelet aggregation and thromboxane production by pinacidil.
    Goodman RP; Little DM; Wright JT
    Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 10. A dominant role of thromboxane formation in secondary aggregation of platelets.
    Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
    Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
    [No Abstract]   [Full Text] [Related]  

  • 11. Formation by phospholipase A2 of prostaglandins and thromboxane A2-like activity in the platelets of normal and essential fatty acid deficient rats. Comparison with effect on human and rabbit platelets.
    Vincent JE; Zijlstra FJ
    Prostaglandins; 1977; 14(6):1043-53. PubMed ID: 601247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin inhibits the formation of endoperoxide metabolites in rat platelets: aspirin-like activity.
    Hwang DH; LeBlanc P
    Prostaglandins Med; 1981 Apr; 6(4):341-4. PubMed ID: 7280114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased biosynthesis of thromboxane A2 by diabetic platelets.
    Ziboh VA; Maruta H; Lord J; Cagle WD; Lucky W
    Eur J Clin Invest; 1979 Jun; 9(3):223-8. PubMed ID: 113223
    [No Abstract]   [Full Text] [Related]  

  • 14. Lithium stimulates thromboxane B2 formation in human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C; van den Berg R; Thomas C
    Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of hydralazine on arachidonic acid metabolism in isolated, washed human platelets.
    Luderer JR; Demers LM; Janson RW; Nomides CT; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):43-52. PubMed ID: 7394316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat.
    Vargaftig BB
    J Pharm Pharmacol; 1978 Feb; 30(2):101-4. PubMed ID: 24092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation by phospholipase A2 of prostaglandins and endoperoxides in platelets of normal and essential fatty acid-deficient rats.
    Vincent JE; Zijlstra FJ
    Adv Prostaglandin Thromboxane Res; 1978; 3():143-6. PubMed ID: 655005
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of dietary vitamin E on platelet thromboxane A2 and vascular prostacyclin I2 in rabbit.
    Pritchard KA; Karpen CW; Merola AJ; Panganamala RV
    Prostaglandins Leukot Med; 1982 Oct; 9(4):373-8. PubMed ID: 6757965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostanoids in blood for neonatal transfusion.
    Mitchell MD; Brunt JD; Wilkinson AR; Turnbull AC
    Lancet; 1978 Dec 23-30; 2(8104-5):1382-3. PubMed ID: 82882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.